World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
October 03, 2007 10:39 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today the appointment of James E.K. Hildreth, M.D., a world...
Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum
October 01, 2007 10:29 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today its CEO, Dr. Janet Greeson, has been invited to speak on a...
Samaritan to Host 2007 Annual Meeting October 23, 2007
September 28, 2007 10:09 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it will host its annual shareholders meeting on Tuesday,...
Update: Samaritan Agrees to Amend Due Date to Receive Second Upfront Payment of $8.6 Million From Pharmaplaz for Its HIV Out-Licensing Deal
September 24, 2007 14:25 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today they have amended the due date to October 16, 2007 for...
EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
September 20, 2007 10:09 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive distribution agreement...
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
September 18, 2007 09:21 ET
|
Samaritan Pharmaceuticals, Inc.
Three Investigational New Drugs (IND) in Pipeline
- Phase II HIV Drug SP-01A
- Phase I Alzheimer's Drug SP-233 Caprospinol
- Phase II Cushing's syndrome SP-6300
LAS VEGAS, Sept. 18, 2007...
Samaritan to Talk Up Its Alzheimer's, HIV and Stem Cell Drugs On NBC Affiliate KVBC Channel 3
August 24, 2007 11:15 ET
|
Samaritan Pharmaceuticals, Inc.
- Don't Miss the CEO of Samaritan On "News 3 At Sunrise"
Sunday, August 26th
- Samaritan is One of Nevada's Largest Pharmaceutical Companies
- Samaritan Videos to Highlight the Substantial...
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
August 21, 2007 09:43 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 21, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
August 16, 2007 11:04 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has exclusively licensed a patent application...
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent Office
August 14, 2007 11:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 14, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that a patent application entitled "NEUROSTEROIDS AS...